Literature DB >> 33345787

Impella 5.5 Direct Aortic Implant and Explant Techniques.

Mark Anderson1, Deane Smith2, Peter Kane3, Raymond Lee4, Zain Khalpey5, Jason Williams6.   

Abstract

The Impella 5.5 with SmartAssist system (Abiomed, Danvers, MA) is approved for the treatment of cardiogenic shock after acute myocardial infarction, cardiac surgery, or in the setting of cardiomyopathy. Designed for full circulatory support and left ventricular unloading the system comprises a catheter-based microaxial pump placed across the aortic valve, pulling blood from the left ventricle and into the ascending aorta. Implantation can be approached through the axillary artery or directly into the aortic root. We present several technical options for implanting, tunneling, and explanting the system using the direct aortic approach and allowing for bedside removal.
Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33345787     DOI: 10.1016/j.athoracsur.2020.09.069

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

Review 1.  A Review of the Impella Devices.

Authors:  Rami Zein; Chirdeep Patel; Adrian Mercado-Alamo; Theodore Schreiber; Amir Kaki
Journal:  Interv Cardiol       Date:  2022-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.